Medical News

Biotechnology, Cancer, Genetics, Longevity, Med Lifestyle, Medical News, Men's health
New blood test uses circulating tumor DNA to help develop personalized cancer treatments

A novel blood test developed at the Vancouver Prostate Center utilizes the DNA of metastatic cancer to help with developing patient-specific treatment plans. DNA from malignant cells and tumors is

Med Lifestyle, Medical News, Metabolic syndrome, Obesity, World health
Non-alcoholic fatty liver disease linked to increased risk of dementia

A Swedish research team has found that patients with NAFLD have an associated 44% increased risk of developing vascular dementia. Non-alcoholic fatty liver disease (NAFLD) is a condition describing the

COVID-19, COVID-19 news, Immunology, Med Lifestyle, Medical News, Pediatrics, World health
Omicron variant of SARS-CoV-2 associated with increased croup virus in children

Researchers at Boston Children’s Hospital have identified a link between increased prevalence of croup among children and the omicron variant of SARS-CoV-2. (Credit: Olga Siletskaya/Moment via Getty Images) The underlying

Biotechnology, Cardiology, Med Lifestyle, Medical News
Researchers develop graphene tattoo that can continuously monitor blood pressure

A group of researchers have developed an ultra-thin, continuous blood pressure monitoring tattoo that can be worn directly on the skin. The researchers believe that this innovation will help aid

COVID-19, COVID-19 news, Immunology, Med Lifestyle, Medical News, Neuroscience, Post-COVID-19 syndrome, World health
Memory impairment and difficulties focusing among the symptoms COVID ‘long-haulers’ continue to face

A UC San Diego research team has revealed the neurological conditions that many people face months following infection by SARS-CoV-2. The first batch of data from the University of California

Biotechnology, Cancer, Gastroenterology, Longevity, Med Lifestyle, Medical News, Pharmaceuticals, World health
Cancer drug shows 100% efficacy in clinical trial involving a dozen patients

A clinical trial assessing the efficacy of drug, Dostarlimab, on a subtype of colorectal cancer was shown to be effective in eliminating cancer in all of the trial’s patients. (Credit: